Valuation: Cutia Therapeutics

Market Cap 756M 876M 112M 98.11M 91.58M 84.04M 157M 10.69B 161M 1.09B 425M 5.29B 419M 410M 18.29B P/E 2026 *
-4.54x
P/E 2027 * 16x
Enterprise Value 825M 955M 122M 107M 99.9M 91.68M 172M 11.67B 176M 1.18B 463M 5.77B 457M 447M 19.96B EV / Sales 2026 *
1.28x
EV / Sales 2027 * 0.64x
Free-Float
35.23%
Yield 2026 *
-
Yield 2027 * -
1 week-7.66%
Current month-14.84%
1 month-10.74%
3 months-47.72%
6 months-47.49%
Current year-46.92%
1 week 2.14
Extreme 2.14
2.67
1 month 2.14
Extreme 2.14
2.88
Current year 2.14
Extreme 2.14
5.51
1 year 2.14
Extreme 2.14
12
3 years 2.14
Extreme 2.14
31
5 years 2.14
Extreme 2.14
32.6
10 years 2.14
Extreme 2.14
32.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-08-31
Director of Finance/CFO 36 2021-05-09
Chief Tech/Sci/R&D Officer 42 2020-01-09
Director TitleAgeSince
Chairman 63 2019-08-22
Director/Board Member 48 2023-06-11
Director/Board Member 57 2025-12-29
Date Insider Type Main position Quantity % Market Cap.
10/15/24 Other

Founder

15,000 0.0049%
10/3/24 Other

Chief Financial Officer

20,000 0.0066%
10/2/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-7.66%-74.79%-88.41% 112M
-0.06%+4.83%+59.80%+168.22% 1,089B
+0.00%+4.17%+58.40%+58.95% 643B
+1.29%+5.13%+39.27%+78.04% 465B
-1.69%+8.81%+39.38%+33.67% 359B
-0.51%+3.51%+36.97%+42.46% 303B
+1.50%+3.40%+17.71%+17.41% 267B
+0.79%+5.81%-2.55%-38.10% 226B
-0.94%+6.44%+28.35%+66.40% 212B
+0.02%+3.07%+17.60%+76.43% 167B
Average +0.04%+3.80%+22.01%+41.51% 373.12B
Weighted average by Cap. +0.03%+5.14%+42.71%+81.78%

Financials

2026 *2027 *
Net sales 646M 748M 95.39M 83.82M 78.24M 71.8M 134M 9.14B 138M 928M 363M 4.52B 358M 350M 15.63B 1.18B 1.37B 174M 153M 143M 131M 246M 16.69B 252M 1.69B 663M 8.26B 654M 640M 28.55B
Net income -146M -169M -21.52M -18.91M -17.65M -16.2M -30.33M -2.06B -31.07M -209M -81.86M -1.02B -80.81M -79.05M -3.53B 44.25M 51.25M 6.53M 5.74M 5.36M 4.92M 9.21M 626M 9.44M 63.56M 24.86M 310M 24.54M 24M 1.07B
Net Debt 68.7M 79.58M 10.15M 8.92M 8.32M 7.64M 14.3M 972M 14.65M 98.68M 38.59M 481M 38.09M 37.27M 1.66B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
304
Date Price Change Volume
26-07-29 HK$2.410 0.00% 400
26-07-28 HK$2.410 -3.60% 30,400
26-07-27 HK$2.500 +3.73% 122,400
26-07-24 HK$2.410 -6.23% 232,400
26-07-23 HK$2.570 +0.78% 32,400
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.081CNY
Average target price
9.801CNY
Spread / Average Target
+371.08%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock